دورية أكاديمية

Characterization of ex vivo and in vivo intraoperative neurosurgical confocal laser endomicroscopy imaging.

التفاصيل البيبلوغرافية
العنوان: Characterization of ex vivo and in vivo intraoperative neurosurgical confocal laser endomicroscopy imaging.
المؤلفون: Yuan Xu, Abramov, Irakliy, Belykh, Evgenii, Mignucci-Jiménez, Giancarlo, Park, Marian T., Eschbacher, Jennifer M., Preul, Mark C.
المصدر: Frontiers in Oncology; 8/24/2022, Vol. 12, p01-14, 14p
مصطلحات موضوعية: INTRACRANIAL tumors, IMAGING systems, CELL imaging, LASERS, MENINGIOMA
مصطلحات جغرافية: FIJI
الشركة/الكيان: UNITED States. Food & Drug Administration
مستخلص: Background: The new US Food and Drug Administration-cleared fluorescein sodium (FNa)-based confocal laser endomicroscopy (CLE) imaging system allows for intraoperative on-the-fly cellular level imaging. Two feasibility studies have been completed with intraoperative use of this CLE system in ex vivo and in vivo modalities. This study quantitatively compares the image quality and diagnostic performance of ex vivo and in vivo CLE imaging. Methods: Images acquired from two prospective CLE clinical studies, one ex vivo and one in vivo, were analyzed quantitatively. Two image quality parameters -- brightness and contrast -- were measured using Fiji software and compared between ex vivo and in vivo images for imaging timing from FNa dose and in glioma, meningioma, and intracranial metastatic tumor cases. The diagnostic performance of the two studies was compared. Results: Overall, the in vivo images have higher brightness and contrast than the ex vivo images (p < 0.001). A weak negative correlation exists between image quality and timing of imaging after FNa dose for the ex vivo images, but not the in vivo images. In vivo images have higher image quality than ex vivo images (p < 0.001) in glioma, meningioma, and intracranial metastatic tumor cases. In vivo imaging yielded higher sensitivity and negative predictive value than ex vivo imaging. Conclusions: In our setting, in vivo CLE optical biopsy outperforms ex vivo CLE by producing higher quality images and less image deterioration, leading to better diagnostic performance. These results support the in vivo modality as the modality of choice for intraoperative CLE imaging. [ABSTRACT FROM AUTHOR]
Copyright of Frontiers in Oncology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:2234943X
DOI:10.3389/fonc.2022.979748